Find out more about the peptide you’re interested in
Browse our guides to individual peptides and related compounds. Each guide explains how the compound works, what researchers have studied, and the safety questions and uncertainties to be aware of. You can search by name or explore a research area below.
Research areas help you navigate the library; they do not mean that a compound has proven benefits or is approved for use.
Recovery & repair
BPC-157
Body Protection Compound 157 · Bepecin · PL-14736
Experimental peptide studied across tendon, ligament, muscle, gastrointestinal and tissue-repair models.
TB-500 / Thymosin Beta-4
TB-500 · Tβ4 fragment · Ac-LKKTETQ
Experimental seven-amino-acid fragment associated with thymosin beta-4 research, but not interchangeable with the full-length 43-amino-acid peptide studied in most wound and eye research.
GHK-Cu
Copper tripeptide-1 · GHK copper peptide
Naturally occurring copper-binding tripeptide studied mainly for skin remodelling, wound repair and related regenerative processes.
KPV
Lysine-proline-valine · α-MSH 11-13
Three-amino-acid fragment of alpha-melanocyte-stimulating hormone studied mainly in cells and animals for possible effects on inflammatory signalling.
ARA-290 / Cibinetide
Cibinetide · ARA 290
Experimental peptide derived from erythropoietin signalling research with interest in tissue protection and inflammation.
LL-37
Cathelicidin LL-37
Human antimicrobial peptide studied in innate immunity, infection, inflammation and wound biology.
Growth hormone & performance
CJC-1295 DAC
DAC:GRF · CJC-1295 with DAC
Modified GHRH(1-29) analogue with an added albumin-binding DAC unit, studied in small early trials for its effects on growth hormone and IGF-1 signalling.
Mod GRF 1-29 / CJC-1295 No DAC
CJC-1295 No DAC · Modified GRF 1-29
Modified 29-amino-acid GHRH fragment commonly called CJC-1295 No DAC, but without direct clinical evidence for the marketed form.
Ipamorelin
NNC 26-0161 · Growth-hormone secretagogue
Investigational five-amino-acid peptide studied for its ability to prompt growth-hormone release and, later, recovery of bowel movement after surgery.
GHRP-2
Pralmorelin · KP-102 · GPA-748
Six-amino-acid ghrelin-receptor agonist used in Japan as a diagnostic test of growth hormone secretion, with limited evidence for treatment.
GHRP-6
Growth hormone-releasing hexapeptide · SKF-110679
Six-amino-acid ghrelin-receptor agonist studied for growth hormone release, endocrine testing and, with EGF, experimental stroke treatment.
Hexarelin
Examorelin · EP-23905 · MF-6003
Six-amino-acid ghrelin-receptor agonist studied in small human endocrine, growth and cardiac physiology experiments, without an approved medical use.
Sermorelin
GHRH(1-29) · GRF(1-29) · Sermorelin acetate
Twenty-nine-amino-acid analogue of the body's growth-hormone-releasing hormone, formerly used in a US-approved medicine for testing and treating some children.
Tesamorelin
EGRIFTA WR · EGRIFTA SV · TH9507
Modified 44-amino-acid GHRH analogue that stimulates endogenous growth hormone release and is used in an approved medicine for excess abdominal fat in adults with HIV-associated lipodystrophy.
HGH Fragment 176-191
hGH 176-191 · Somatotropin (176-191)
Sixteen-amino-acid C-terminal fragment of human growth hormone studied mainly in older cell and animal metabolism research, without direct human clinical evidence.
AOD-9604
Tyr-hGH 177-191 · Modified GH fragment
Modified growth-hormone fragment studied for obesity, with positive animal findings but an unsuccessful human Phase 2b development programme.
IGF-1 LR3
Long R3 IGF-1 · LR3-IGF-I
Engineered 83-amino-acid IGF-1 analogue designed to bind weakly to IGF-binding proteins, with laboratory and animal research but no approved human use.
MGF
Mechano Growth Factor · IGF-1Ec · MGF E peptide
Name used for the mechanically responsive IGF-1Ec splice variant and synthetic E-domain peptides studied in muscle, repair and cell-signalling research.
PEG-MGF
PEGylated Mechano Growth Factor · Pegylated MGF
PEG-conjugated research compound marketed from the MGF E-peptide concept, without a standardised clinical product or identified human exposure evidence.
Follistatin-344
FST-344
Follistatin isoform studied for its interaction with activin and myostatin-related signalling pathways.
Metabolic & weight research
Semaglutide
Ozempic · Wegovy · Rybelsus
Modified GLP-1 peptide used in approved medicines for type 2 diabetes, long-term weight management, cardiovascular risk reduction and certain other conditions.
Tirzepatide
Mounjaro · Zepbound · LY3298176
Modified 39-amino-acid peptide and dual GIP and GLP-1 receptor agonist used in approved medicines for type 2 diabetes, weight management and obstructive sleep apnoea.
Retatrutide
LY3437943 · Triple agonist
Investigational peptide that activates GIP, GLP-1 and glucagon receptors and is being studied for obesity, type 2 diabetes and related conditions.
Cagrilintide
AM833 · Long-acting amylin analogue · CagriSema component
Long-acting amylin analogue developed by Novo Nordisk and studied alone and with semaglutide for weight management and type 2 diabetes.
Mazdutide
IBI362 · LY3305677
GLP-1 and glucagon receptor dual agonist investigated for obesity and metabolic disease.
Survodutide
BI 456906
GLP-1 and glucagon receptor dual agonist studied in obesity and metabolic liver disease.
Mitochondrial & longevity research
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c · MRWQEMGYIFYPRKLR
Sixteen-amino-acid peptide first described in 2015 and studied as a signal connecting mitochondrial activity with metabolism, stress and exercise.
SS-31 / Elamipretide
Elamipretide
Mitochondria-targeting peptide investigated for mitochondrial function, oxidative stress and tissue energy metabolism.
Humanin
Mitochondrial-derived peptide studied in cellular stress resistance, metabolism and age-related biology.
Epitalon
Epithalon · AEDG · Ala-Glu-Asp-Gly
Synthetic four-amino-acid peptide associated with Russian pineal-peptide research, with cell and animal findings but no established human anti-ageing treatment benefit.
Neuro & cognitive research
Semax
ACTH(4-7)-Pro-Gly-Pro · Met-Glu-His-Phe-Pro-Gly-Pro
Seven-amino-acid peptide developed in Russia and studied for possible effects on the brain, particularly after an ischaemic stroke.
Selank
TP-7 · Thr-Lys-Pro-Arg-Pro-Gly-Pro
Seven-amino-acid synthetic peptide derived from the tuftsin sequence and studied mainly in Russian anxiety and neurobiology research.
N-Acetyl Semax
Modified Semax-related research compound discussed in experimental neurobiological and cognitive research.
N-Acetyl Selank
Modified Selank-related research compound discussed in experimental neurobiological and stress-response research.
DSIP
Delta sleep-inducing peptide · WAGGDASGE · Emideltide
Nine-amino-acid experimental peptide first linked to sleep in the 1970s, with small and inconsistent human studies and no established approved treatment use.
Other high-interest peptides
PT-141 / Bremelanotide
Bremelanotide · Vyleesi · PL-6983
Synthetic cyclic melanocortin peptide used in the FDA-approved medicine Vyleesi for acquired, generalised low sexual desire in certain premenopausal women.
Melanotan II
MT-II · Melanotan 2
Unapproved cyclic melanocortin analogue studied in small human pigmentation and erectile-response trials, with important product-quality and safety concerns.
Thymosin Alpha-1
Thymalfasin · Tα1 · Zadaxin
Acetylated 28-amino-acid peptide involved in immune signalling, used as a medicine in some countries but not FDA approved and supported by mixed condition-specific evidence.
Kisspeptin-10
Kisspeptin · KP-10 · KISS1 112-121
Ten-amino-acid KISS1 fragment studied as an upstream stimulator of GnRH and gonadotrophin release.
Additional research compounds
ACE-031
Experimental activin receptor fusion protein investigated in muscle-growth and myostatin-related pathways.
B7-33
Relaxin-2 B-chain analogue
Single-chain relaxin-2 analogue studied through RXFP1 signalling in preclinical fibrosis and cardiovascular models.
FOXO4-DRI
FOXO4 D-retro-inverso peptide
Experimental D-retro-inverso peptide studied as a FOXO4-p53-disrupting senolytic in cells and animal models.
Adipotide / FTPP
FTPP · Prohibitin-TP01
Prohibitin-targeted pro-apoptotic peptidomimetic that reduced white fat in animals but produced kidney effects in primates.
Gonadorelin
Gonadotropin-releasing hormone · GnRH · LHRH
Synthetic form of the natural ten-amino-acid reproductive hormone GnRH, formerly approved in US human diagnostic and fertility products that are no longer marketed.
Triptorelin
Trelstar · Triptodur · Decapeptyl · Gonapeptyl
Long-acting GnRH agonist used for product-specific oncology, endocrine and reproductive indications.
Oxytocin
Oxytocin injection · Pitocin
Endogenous nine-amino-acid hormone with established roles in labour and milk ejection, and a regulated medicine for defined obstetric uses.
Melanotan I
Afamelanotide · NDP-alpha-MSH · Nle4,D-Phe7-alpha-MSH
Linear alpha-MSH analogue developed as afamelanotide, the active peptide in a regulated implant for erythropoietic protoporphyria.
P21 / P021
P021 · CNTF-derived peptidomimetic
CNTF-derived experimental peptidomimetic studied in rodent neurogenesis, synaptic and cognition models.
PE-22-28
PE 22-28 · Shortened spadin analogue
Seven-amino-acid spadin fragment studied as a TREK-1 blocker in cell and mouse depression-related models.
Pinealon
EDR · Glu-Asp-Arg
Synthetic EDR tripeptide studied in cell and animal neurobiology, with small, limited-quality human reports.
Thymalin
Calf-thymus polypeptide extract
Animal thymus-derived polypeptide mixture studied historically in immune dysfunction and ageing research.
Thymagen / Thymogen
Thymogen · L-Glu-L-Trp · EW · IM862 · Oglufanide
Synthetic L-Glu-L-Trp dipeptide studied in immune research and negative controlled cancer trials.
Vilon
Lys-Glu · KE peptide
Synthetic Lys-Glu dipeptide studied mainly in immune-cell, chromatin and gene-expression experiments.
PNC-27
p53-penetratin peptide
Experimental p53-derived peptide studied for membrane-HDM2 targeting and pore formation in cancer cells and mice.
PTD-DBM
Protein transduction domain–Dishevelled-binding motif
Experimental peptide investigated in Wnt signalling and hair-follicle biology.
Bronchogen
AEDL peptide · ADEL peptide
Short peptide preparation discussed in experimental respiratory and tissue-regulation research.
Cardiogen
AEDR peptide · Ala-Glu-Asp-Arg
Short peptide preparation studied in experimental cardiovascular and tissue-regulation research.
Cartalax
Kartalax · AED peptide · Ala-Glu-Asp
Short peptide preparation discussed in experimental cartilage and connective-tissue research.
Chonluten
EDG peptide · Glu-Asp-Gly
Short peptide preparation discussed in experimental respiratory and tissue-regulation research.
Cortagen
AEDP peptide · Ala-Glu-Asp-Pro
Short peptide preparation investigated in experimental nervous-system and ageing research.
Livagen
KEDA peptide · Lys-Glu-Asp-Ala
Short peptide preparation discussed in experimental liver and tissue-regulation research.
Ovagen
EDL peptide · Glu-Asp-Leu · T-35
Short peptide preparation discussed in experimental reproductive and tissue-regulation research.
Pancragen
KEDW peptide · Lys-Glu-Asp-Trp
Short peptide preparation discussed in experimental pancreatic and metabolic research.
Prostamax
KEDP peptide · Lys-Glu-Asp-Pro
Short peptide preparation discussed in experimental prostate and tissue-regulation research.
Testagen
KEDG peptide · Lys-Glu-Asp-Gly
Short peptide preparation discussed in experimental reproductive and endocrine research.
Vesilut
Vesilute · ED peptide · Glu-Asp
Short peptide preparation discussed in experimental urinary-system and tissue-regulation research.
Vesugen
Vezugen · KED peptide · Lys-Glu-Asp
Short peptide preparation discussed in experimental vascular and tissue-regulation research.
VIP
Vasoactive Intestinal Peptide · Aviptadil
Endogenous 28-amino-acid neuropeptide involved in vascular, gastrointestinal, pulmonary, neural and immune signalling.
Adjacent research compounds
These compounds commonly appear alongside peptides in research and commercial discussions, but they are not themselves peptides.
NAD+
Nicotinamide Adenine Dinucleotide
Natural cellular coenzyme central to energy metabolism and signalling. Direct NAD+ treatment has limited clinical evidence and is not an established anti-ageing therapy.
AICAR
Acadesine · AICA riboside
Purine-related nucleoside studied as an AMPK activator and adenosine-regulating agent; not a peptide.
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMT inhibitor · 5A1MQ
Experimental small-molecule inhibitor of nicotinamide N-methyltransferase studied in cells and animals. It is not a peptide and has no established human treatment evidence.
How to read the evidence in these guides
Findings from laboratory or animal studies do not establish that a compound works in people. Our guides distinguish these types of research and link to the sources, so you can explore the findings and their limitations. The human-research labels summarise the evidence; they are not safety ratings or recommendations.
Research methodologyRead about our research approach →